Diagnostic accuracy of faecal calprotectin in patients with active perianal fistulas.


Journal

United European gastroenterology journal
ISSN: 2050-6406
Titre abrégé: United European Gastroenterol J
Pays: England
ID NLM: 101606807

Informations de publication

Date de publication:
05 2019
Historique:
received: 10 09 2018
accepted: 03 02 2019
entrez: 9 5 2019
pubmed: 9 5 2019
medline: 9 5 2019
Statut: ppublish

Résumé

Faecal calprotectin (FC) is a marker of mucosal inflammation. The aim of this study was to determine the diagnostic accuracy of FC to (a) differentiate between perianal fistulizing Crohn's disease (pCD) and cryptoglandular perianal fistulas; and (b) detect mucosal inflammation in pCD. Patients with active perianal fistulas who had FC measured and a complete ileocolonoscopy within 10 weeks were retrospectively included. Fifty-six patients were included (pCD, FC discriminates pCD from cryptoglandular fistulas, even in the absence of intestinal ulcers. In active pCD, an elevated FC does not accurately predict the presence of ulcers and should be interpreted with caution.

Sections du résumé

Background
Faecal calprotectin (FC) is a marker of mucosal inflammation.
Objective
The aim of this study was to determine the diagnostic accuracy of FC to (a) differentiate between perianal fistulizing Crohn's disease (pCD) and cryptoglandular perianal fistulas; and (b) detect mucosal inflammation in pCD.
Methods
Patients with active perianal fistulas who had FC measured and a complete ileocolonoscopy within 10 weeks were retrospectively included.
Results
Fifty-six patients were included (pCD,
Conclusion
FC discriminates pCD from cryptoglandular fistulas, even in the absence of intestinal ulcers. In active pCD, an elevated FC does not accurately predict the presence of ulcers and should be interpreted with caution.

Identifiants

pubmed: 31065367
doi: 10.1177/2050640619834464
pii: 10.1177_2050640619834464
pmc: PMC6488796
doi:

Substances chimiques

Biomarkers 0
Leukocyte L1 Antigen Complex 0

Types de publication

Journal Article Observational Study

Langues

eng

Pagination

496-506

Références

Gastroenterology. 2015 Oct;149(5):1275-1285.e2
pubmed: 26166315
Gut. 2014 Sep;63(9):1381-92
pubmed: 24951257
Scand J Gastroenterol. 2015 Jul;50(7):841-7
pubmed: 25636819
J Crohns Colitis. 2014 Dec;8(12):1582-97
pubmed: 25267173
Br J Pharmacol. 2008 Dec;155(7):1085-92
pubmed: 18806816
Clin Gastroenterol Hepatol. 2006 Sep;4(9):1130-4
pubmed: 16905369
Scand J Gastroenterol. 2012 Jul;47(7):778-84
pubmed: 22519419
N Engl J Med. 2010 Apr 15;362(15):1383-95
pubmed: 20393175
Am J Gastroenterol. 2010 Jan;105(1):162-9
pubmed: 19755969
N Engl J Med. 1999 May 6;340(18):1398-405
pubmed: 10228190
Gastroenterology. 2002 Apr;122(4):875-80
pubmed: 11910338
Inflamm Bowel Dis. 2014 Nov;20(11):2092-103
pubmed: 25137418
Int J Colorectal Dis. 2007 Dec;22(12):1459-62
pubmed: 17554546
J Crohns Colitis. 2017 Jan;11(1):3-25
pubmed: 27660341
Gut. 1995 Mar;36(3):407-10
pubmed: 7698701
Ann Intern Med. 2003 Jan 7;138(1):40-4
pubmed: 12513043
Inflamm Bowel Dis. 2012 Dec;18(12):2218-24
pubmed: 22344983
Int J Colorectal Dis. 1992 Dec;7(4):214-8
pubmed: 1293243
Scand J Gastroenterol. 1999 Jan;34(1):50-4
pubmed: 10048733
Ann Surg. 1938 Nov;108(5):867-73
pubmed: 17857277
Inflamm Bowel Dis. 2013 Apr;19(5):1043-52
pubmed: 23511035
Gastrointest Endosc. 2006 Mar;63(3):433-42; quiz 464
pubmed: 16500392
Am J Gastroenterol. 2001 Sep;96(9):2683-7
pubmed: 11569695
J Crohns Colitis. 2015 Dec;9(12):1113-9
pubmed: 26351383
J Crohns Colitis. 2013 Dec;7(12):e641-51
pubmed: 23810085
Inflamm Bowel Dis. 2010 Jul;16(7):1091-2
pubmed: 19834972
Inflamm Bowel Dis. 2008 Jan;14(1):40-6
pubmed: 18022866
Colorectal Dis. 2015 Dec;17(12):1041-3
pubmed: 26547817
Gastroenterology. 2012 May;142(5):1102-1111.e2
pubmed: 22326435
J Crohns Colitis. 2013 Dec;7(12):982-1018
pubmed: 24184171
World J Gastrointest Pathophysiol. 2014 Aug 15;5(3):239-51
pubmed: 25133026
Gut. 1980 Jun;21(6):525-7
pubmed: 7429313
J Leukoc Biol. 2001 Jul;70(1):130-4
pubmed: 11435495
World J Gastrointest Pathophysiol. 2014 Aug 15;5(3):205-12
pubmed: 25133023
Inflamm Bowel Dis. 2016 Mar;22(3):623-30
pubmed: 26829408

Auteurs

Toer W Stevens (TW)

Department of Gastroenterology and Hepatology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Geert R D'Haens (GR)

Department of Gastroenterology and Hepatology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Marjolijn Duijvestein (M)

Department of Gastroenterology and Hepatology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Willem A Bemelman (WA)

Department of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Christianne J Buskens (CJ)

Department of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Krisztina B Gecse (KB)

Department of Gastroenterology and Hepatology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH